Corcept Therapeutics CORT
NASDAQ CORT
$115.79 +1.76 (+1.54%)
As of: Oct 2, 2026 · 2:34 PM EDT

Corcept Therapeutics (CORT) Profit After Tax (2010 - 2026)

Updated

Corcept Therapeutics' Profit After Tax was $42.99 million in Q2 2026, up 22.1% from $35.19 million a year earlier.

Analysis

Corcept Therapeutics (CORT) Profit After Tax (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Corcept Therapeutics' Profit After Tax was $55.23 million through Jun 30, 2026, down 58.7% year-over-year; for FY2025, it came in at $99.65 million, down 29.4% from FY2024.

  • Profit After Tax shows a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
  • In earlier years, Profit After Tax was $141.21 million in FY2024 (+33.0%), $106.14 million in FY2023 (+4.7%), $101.42 million in FY2022 (-9.9%) and $112.51 million in FY2021 (+6.1%).
  • The Q2 2026 figure marks the highest quarterly Profit After Tax since Q3 2024.
  • Compared with a year earlier, Profit After Tax was higher in two of the last seven quarters, with an average decline of 5.1%.
  • The best year-over-year quarter for Profit After Tax over five years was Q4 2023 (growth of 89.1%); the worst was Q3 2025 (a decline of 58.3%).
  • Per Business Quant data, CORT's Profit After Tax in the three quarters before Q2 2026 was -$31.72 million (Q1 2026), $24.29 million (Q4 2025) and $19.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.28 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.09 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -246.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 Corcept Therapeutics 12.46 Bn 11.02 Bn 252.09 Mn 42.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.99 Mn
Mar 31, 2026 -31.72 Mn
Dec 31, 2025 24.29 Mn
Sep 30, 2025 19.67 Mn
Jun 30, 2025 35.19 Mn
Mar 31, 2025 20.55 Mn
Dec 31, 2024 30.78 Mn
Sep 30, 2024 47.21 Mn
Jun 30, 2024 35.49 Mn
Mar 31, 2024 27.76 Mn
Dec 31, 2023 31.39 Mn
Sep 30, 2023 31.38 Mn
Jun 30, 2023 27.53 Mn
Mar 31, 2023 15.83 Mn
Dec 31, 2022 16.60 Mn
Sep 30, 2022 34.61 Mn
Jun 30, 2022 27.36 Mn
Mar 31, 2022 22.75 Mn
Dec 31, 2021 32.05 Mn
Sep 30, 2021 30.47 Mn
API Access

Corcept Therapeutics Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=CORT&period=max&api_key=YOUR_API_KEY